Cellular senescence in the aging and diseased kidney
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index.
Abstract
The program of cellular senescence is involved in both the G1 and G2 phase of the cell cycle, limiting G1/S and G2/M progression respectively, and resulting in prolonged cell cycle arrest. Cellular senescence is involved in normal wound healing. However, multiple organs display increased senescent cell numbers both during natural aging and after injury, suggesting that senescent cells can have beneficial as well as detrimental effects in organismal aging and disease. Also in the kidney, senescent cells accumulate in various compartments with advancing age and renal disease. In experimental studies, forced apoptosis induction through the clearance of senescent cells leads to better preservation of kidney function during aging. Recent groundbreaking studies demonstrate that senescent cell depletion through INK-ATTAC transgene-mediated or cell-penetrating FOXO4-DRI peptide induced forced apoptosis, reduced age-associated damage and dysfunction in multiple organs, in particular the kidney, and increased performance and lifespan. Senescence is also involved in oncology and therapeutic depletion of senescent cells by senolytic drugs has been studied in experimental and human cancers. Although studies with senolytic drugs in models of kidney injury are lacking, their dose limiting side effects on other organs suggest that targeted delivery might be needed for successful application of senolytic drugs for treatment of kidney disease. In this review, we discuss (i) current understanding of the mechanisms and associated pathways of senescence, (ii) evidence of senescence occurrence and causality with organ injury, and (iii) therapeutic strategies for senescence depletion (senotherapy) including targeting, all in the context of renal aging and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These persisting senescent cells have been recently tied to multiple chronic diseases other than atherosclerosis, including diabetes mellitus,85 obesity,85 Alzheimer’s disease,86 heart failure,10,87 idiopathic pulmonary fibrosis,88,89 chronic obstructive pulmonary disease,90 chronic kidney disease,91 cancer,92 and osteoarthritis.93”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 1×
“DDR induced prolonged CCA in senescence is characterized by accumulation of cyclin dependent kinase inhibitors (CKIs) like tumor protein p53 (TP53 or p53), p21CIP1 (p21) and p16INK4a (p16) (el-Deiry et al. 1993; Harper et al. 1993).”
BackgroundA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“(,,(Dimri et al. 1995; Krishnamurthy et al. 2004; Burd et al. 2013)).”
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 1×
“Following DNA damage, the DDR arrests cell cycle progression at specific checkpoints, particularly the G1/S checkpoint, thereby allowing time for DNA repair to prevent that errors are replicated or passed on to daughter cells in mitosis (Jackson and Bartek 2009).”
BackgroundThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“DDR induced prolonged CCA in senescence is characterized by accumulation of cyclin dependent kinase inhibitors (CKIs) like tumor protein p53 (TP53 or p53), p21CIP1 (p21) and p16INK4a (p16) (el-Deiry et al. 1993; Harper et al. 1993).”
BackgroundDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“Thirdly, the G2/M checkpoint is not as efficient in inducing CCA as the G1-S checkpoint, which relies on strong p21 induction (Löbrich and Jeggo 2007; Cesare et al. 2013).”
BackgroundGlobal Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030 · cited 1×
“In 2016, the global prevalence of CKD was estimated to be as much as 13.4%, forming a global health burden with a high economic cost to health systems worldwide (Hill et al. 2016).”
BackgroundInfluentialA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“…causes Rb to remain attached to and thereby inhibit the transcriptionally active E2F protein complex, thus preventing G1/S transition and DNA replication, or G2/M progression and mitosis, ultimately limiting cellular proliferation (Zhang et al. 1993; Serrano et al. 1993; Jullien et al. 2013) (Fig.”
BackgroundNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 4×
“…in mice Study Model of kidney injury Method of senescence intervention Acute and long-term outcome (days after kidney injury) Effect of senescence (Baker et al. 2016) Natural aging (1-year old) p16-KO Attenuated glomerulosclerosis Detrimental: contributing to renal aging (Wolstein et al. 2010)…”
BackgroundInfluentialThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 3×
“So called ‘senolytics’ interfere with anti-apoptotic and pro-survival signaling, thereby eliminating senescent cells (Zhu et al. 2015).”
BackgroundSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 1×
“SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), a member of the growth promoting pathway MAPK playing an essential role in inflammatory responses, including the SASP (Bennett et al. 2001).”
BackgroundSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“Mechanistically, senescent cells can act cell-autonomously by induction of CCA and non-cellautonomously by influencing neighboring cells through proteins that are part of the senescence-associated secretory phenotype (SASP) (Xue et al. 2007).”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Thus, increased numbers of senescent cells were found in association with glomerulosclerosis and tubulointerstitial changes (Ding et al. 2001; Chkhotua et al. 2003; Melk et al. 2003; Melk et al. 2004).”
BackgroundCellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093 · cited 1×
“Antioxidants might be beneficial by reducing ROS-mediated DNA damage and thereby preventing DDR-induced senescence (Holmström and Finkel 2014).”
BackgroundAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045 · cited 1×
“…senescent cells have been pointed out, including impaired cutaneous wound healing and increased fibrosis upon liver damage, underscoring the critical positive contribution of naturally occurring cellular senescence to (acute) regenerative processes (Krizhanovsky et al. 2008; Demaria et al. 2014).”
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 11×
“Prolonged CCA is a key feature of senescence and is mediated via induction of the DDR.”
BackgroundInfluentialChen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816 · cited 1×
“These so-called senotherapies can be broadly divided according to three different approaches (Childs et al. 2015):”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · cited 16×
“Secondly, SASP modulation could impede immune surveillance, and hamper elimination of senescent cells.”
BackgroundInfluentialSenescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · cited 1×
“(,,(Dimri et al. 1995; Krishnamurthy et al. 2004; Burd et al. 2013)).”
Baar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454 · cited 4×
“…detection reagents, FACS Cell cycle arrest Cyclin-dependent kinase inhibitors (p21CIP1, p16INKa, p19ARF, p14ARF, p27KIP1, p15Ink4b) IHC, qPCR Abbreviations: IHC = immunohistochemistry; qPCR= quantitative PCR; EM= electron microscopy; WB =Western blot apoptosis (Baar et al. 2017).”
BackgroundInfluentialEpithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V., & Bonventre, J. V. (2010) · Nature Medicine · doi:10.1038/nm.2144 · Cited by 1,333 · cited 7×
“This holds true especially G2-arrested senescent cells (Yang et al. 2010; Bonventre 2014a).”
BackgroundInfluentialLiving on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · cited 1×
“Firstly, replicative senescence applies mainly to G2 arrest as telomere attrition preferentially triggers DDR at the G2/M checkpoint (d'Adda di Fagagna 2008; Jullien et al. 2013; Mao et al. 2014).”
BackgroundZhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“…in HUVECs, and by the natural product piperlongumine which caused apoptosis of senescent human WI-38 fibroblasts, no matter whether senescence was induced by either ionizing radiation, or replicative exhaustion, or ectopic expression of the Ras oncogene (Zhu et al. 2016; Wang et al. 2016).”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 3×
“Typical phenotypic traits are permanent CCA, persistent DDR, SASP, epigenetic changes like senescence-associated heterochromatic foci (SAHFs), altered metabolism including increased lysosomal and proteasomal activity, and telomere shortening and dysfunction (Sharpless and Sherr 2015; Matjusaitis et al. 2016b).”
BackgroundInfluentialO'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J., Cowan-Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0259 · Cited by 1,036 · cited 1×
“These anti-tumor agents are known for inhibiting a broad spectrum of protein kinases and tyrosine kinases(O'Hare et al. 2005; Russo et al. 2012).”
BackgroundDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032 · cited 1×
“It is regarded as a pan-BCL inhibitor, as it is known to cause apoptosis in various cell types by inhibiting the anti-apoptotic BCL family members, including BCL-2, BCL-XL and BCLW (Chang et al. 2016; Yosef et al. 2016).”
BackgroundProgrammed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031 · cited 1×
“For instance, navitoclax caused dosedependent thrombocytopenia, due to inhibition of BCL-X in platelets resulting in platelet apoptosis (Mason et al. 2007; Zhang et al. 2007; Wilson et al. 2010).”
BackgroundJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 2×
“For instance, the matricellular protein CCN1 (also known as CYR61) induces senescence of fibroblasts in cutaneous wound healing and of liver myofibroblasts in hepatic injury, and its expression is linked to reduced fibrosis (Jun and Lau 2010; Kim et al. 2013).”
BackgroundDatto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950 · cited 4×
“Although its role in the kidney remains unclear, CCN1 expression is also elevated in several senescence-associated human pathologies beyond the liver, including atherosclerosis, which suggests a possible role in age-related diseases (Littlewood and Bennett 2007).”
BackgroundInfluentialWilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876 · cited 1×
“For instance, navitoclax caused dosedependent thrombocytopenia, due to inhibition of BCL-X in platelets resulting in platelet apoptosis (Mason et al. 2007; Zhang et al. 2007; Wilson et al. 2010).”
BackgroundRegulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 1×
“(Gil and Peters 2006; Aan et al. 2013).”
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Inoki, K., Kim, J., & Guan, K.-L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134537 · Cited by 791 · cited 16×
“Secondly, SASP modulation could impede immune surveillance, and hamper elimination of senescent cells.”
BackgroundInfluentialZhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T., & Kirkland, J. L. (2017) · Aging · doi:10.18632/aging.101202 · Cited by 757
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735 · cited 11×
“Prolonged CCA is a key feature of senescence and is mediated via induction of the DDR.”
BackgroundInfluentialDrugging the p53 pathway: understanding the route to clinical efficacy
Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 719 · cited 2×
“The absolute levels of p53 expression seem to be decisive in determining cell fate (Khoo et al. 2014).”
BackgroundThe flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698 · cited 1×
“These anti-tumor agents are known for inhibiting a broad spectrum of protein kinases and tyrosine kinases(O'Hare et al. 2005; Russo et al. 2012).”
BackgroundMitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases
Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., & Sassone-Corsi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.874-885.2002 · Cited by 666 · cited 4×
“Although its role in the kidney remains unclear, CCN1 expression is also elevated in several senescence-associated human pathologies beyond the liver, including atherosclerosis, which suggests a possible role in age-related diseases (Littlewood and Bennett 2007).”
BackgroundInfluentialASPP Proteins Specifically Stimulate the Apoptotic Function of p53
Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., & Lu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00367-7 · Cited by 664 · cited 1×
“Pro-apoptotic proteins that are directly upregulated by p53 also include BAX and p53-inducible protein 3 (PIG3) (Samuels-Lev et al. 2001).”
BackgroundThe senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka, B., Storer, M., Mas, A., Heinzmann, F., Ortells, M. C., Morton, J. P., Sansom, O. J., Zender, L., & Keyes, W. M. (2017) · Genes & Development · doi:10.1101/gad.290635.116 · Cited by 650 · cited 1×
“…to cellular senescence also in other conditions, including tumor biology and liver regeneration, where SASP can mediate paracrine effects of senescent cells, inducing either stemness or senescence in neighboring cells, depending on short or long duration, respectively (Ritschka et al. 2017).”
BackgroundThe impact of a negligent G2/M checkpoint on genomic instability and cancer induction
Löbrich, M., & Jeggo, P. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2248 · Cited by 632 · cited 1×
“Thirdly, the G2/M checkpoint is not as efficient in inducing CCA as the G1-S checkpoint, which relies on strong p21 induction (Löbrich and Jeggo 2007; Cesare et al. 2013).”
BackgroundReplicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547 · cited 3×
“of the cell-cycle, but it does occur also in G2 (see below) (Stein and Dulić 1995; Smith and Pereira-Smith 1996).”
BackgroundSynthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541 · cited 1×
“Senescent cells have much in common with cancer cells, including similarities in metabolic activity, the DDR and activation of pro-survival pathways or inhibition of pro-apoptotic pathways (Ghosal and Chen 2013; Dörr et al. 2013).”
BackgroundThe biology of replicative senescence
Campisi, J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00058-5 · Cited by 537 · cited 1×
“1) (Campisi 1997; Toussaint et al. 2000).”
Rodier, F., Muñoz, D. P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., Coppé, J.-P., Campeau, E., Beauséjour, C. M., Kim, S.-H., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.071340 · Cited by 535 · cited 3×
“…box protein O4 (FOXO4) that binds and retains p53 to persistent nuclear foci containing DDR proteins termed ‘DNA segments with chromatin alterations reinforcing senescence’ (DNA-SCARS) that associate with PML (promyelocytic leukemia protein) nuclear bodies (Rodier et al. 2011; Baar et al. 2017).”
BackgroundTargeting kidney mesangium by nanoparticles of defined size
Choi, C. H. J., Zuckerman, J. E., Webster, P., & Davis, M. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103573108 · Cited by 502 · cited 1×
“Targeting of PTCs, which display features of senescence with aging and pathology, may be the most promising approach, as these cells are highly active in accumulating compounds from the filtered urine via their receptors in the luminal brush-border (Christensen et al. 2012).”
BackgroundRenal Aging: Causes and Consequences
O’Sullivan, E. D., Hughes, J., & Ferenbach, D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121308 · Cited by 484 · cited 11×
“G al T ub ul es Te lo m er e sh or te ni ng T he ra py in du ce d (Z ho u et al .2 00 4) C is pl at in R at p2 1, p2 7 T ub ul es D N A re pa ir (M el k et al .2 00 5) D el ay ed gr af tf un ct io n an d di se as ed na tiv e ki dn ey s H um an p1 6 G lo m er ul i, tu bu lo in te rs tit iu m , ar te ri es T ub ul ar at…”
BackgroundInfluentialBcl-2 family proteins are essential for platelet survival
Zhang, H., Nimmer, P. M., Tahir, S. K., Chen, J., Fryer, R. M., Hahn, K. R., Iciek, L. A., Morgan, S. J., Nasarre, M. C., Nelson, R., et al. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402081 · Cited by 427 · cited 1×
“For instance, navitoclax caused dosedependent thrombocytopenia, due to inhibition of BCL-X in platelets resulting in platelet apoptosis (Mason et al. 2007; Zhang et al. 2007; Wilson et al. 2010).”
BackgroundMonitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419 · cited 1×
“1) (Campisi 1997; Toussaint et al. 2000).”
Metformin reduces endogenous reactive oxygen species and associated DNA damage
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0536 · Cited by 372 · cited 5×
“Metformin also reduces the production of ROS (Algire et al. 2012).”
BackgroundInfluentialProliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.
Zhang, H., Xiong, Y., & Beach, D. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.897 · Cited by 362 · cited 1×
“…causes Rb to remain attached to and thereby inhibit the transcriptionally active E2F protein complex, thus preventing G1/S transition and DNA replication, or G2/M progression and mitosis, ultimately limiting cellular proliferation (Zhang et al. 1993; Serrano et al. 1993; Jullien et al. 2013) (Fig.”
BackgroundMelk, A., Schmidt, B. M. W., Takeuchi, O., Sawitzki, B., Rayner, D. C., & Halloran, P. F. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00438.x · Cited by 362 · cited 3×
“Thus, increased numbers of senescent cells were found in association with glomerulosclerosis and tubulointerstitial changes (Ding et al. 2001; Chkhotua et al. 2003; Melk et al. 2003; Melk et al. 2004).”
BackgroundCellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345 · cited 3×
“…acid toxic nephropathy; KO= genetic knock-out IRI and multiple hit models with their cumulative, diverse stresses, and also the observations on senescent cell depletion during normal and accelerated aging will be most relevant (Bonventre 2014a; Le Clef et al. 2016; Sturmlechner et al. 2017).”
BackgroundsiRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111204 · Cited by 337 · cited 1×
“In mouse models of ischemic and cisplatininduced acute kidney injury, intravenous administration of siRNA against p53 reduces cellular p53 and attenuates p53mediated apoptosis (Molitoris et al. 2009).”
BackgroundCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy
Verzola, D., Gandolfo, M. T., Gaetani, G., Ferraris, A., Mangerini, R., Ferrario, F., Villaggio, B., Gianiorio, F., Tosetti, F., Weiss, U., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90302.2008 · Cited by 302 · cited 6×
“In DN, tubular SA-β-Gal expression correlates with body mass index (BMI) and blood glucose, and tubular p16 is associated with BMI, LDL cholesterol and HbA1c (Verzola et al. 2008).”
BackgroundInfluentialSenescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300 · cited 1×
“(Gire and Dulic 2015).”
Diverse origins of the myofibroblast—implications for kidney fibrosis
Falke, L. L., Gholizadeh, S., Goldschmeding, R., Kok, R. J., & Nguyen, T. Q. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.246 · Cited by 299
Self-citationEndocytic Receptors in the Renal Proximal Tubule
Christensen, E. I., Birn, H., Storm, T., Weyer, K., & Nielsen, R. (2012) · Physiology · doi:10.1152/physiol.00022.2012 · Cited by 287 · cited 8×
“G al T ub ul es Te lo m er e sh or te ni ng T he ra py in du ce d (Z ho u et al .2 00 4) C is pl at in R at p2 1, p2 7 T ub ul es D N A re pa ir (M el k et al .2 00 5) D el ay ed gr af tf un ct io n an d di se as ed na tiv e ki dn ey s H um an p1 6 G lo m er ul i, tu bu lo in te rs tit iu m , ar te ri es T ub ul ar at…”
BackgroundInfluentialIglesias-Bartolome, R., Patel, V., Cotrim, A., Leelahavanichkul, K., Molinolo, A. A., Mitchell, J. B., & Gutkind, J. S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.06.007 · Cited by 284 · cited 1×
“The pro-inflammatory pathways of the SASP can also be targeted by the mTOR inhibitor rapamycin or the AMPK activator metformin, leading to prevention of senescence (Iglesias-Bartolome et al. 2012; Noren Hooten et al. 2016).”
BackgroundDiscovery of piperlongumine as a potential novel lead for the development of senolytic agents
Wang, Y., Chang, J., Liu, X., Zhang, X., Zhang, S., Zhang, X., Zhou, D., & Zheng, G. (2016) · Aging · doi:10.18632/aging.101100 · Cited by 274
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.
Kracikova, M., Akiri, G., George, A., Sachidanandam, R., & Aaronson, S. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.155 · Cited by 261 · cited 1×
“High levels of p53 lead to apoptosis and lower levels result in temporary CCA (Chen et al. 1996; Kracikova et al. 2013).”
BackgroundKim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-13 · Cited by 261
Nanomedicines for renal disease: current status and future applications
Kamaly, N., He, J. C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 250 · cited 1×
“Targeting other renal cell types (i.e. mesangial cells, endothelial cells and podocytes) is theoretically possible through targeting of different surface receptors, using nanoparticles, or with liposomes(Tuffin et al. 2005; Choi et al. 2011; Kamaly et al. 2016).”
Cell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217 · cited 1×
“This is opposed to quiescence, which is a temporary state of CCA due to a lack of growth stimulation (Blagosklonny 2011).”
BackgroundMelk, A., Kittikowit, W., Sandhu, I., Halloran, K. M., Grimm, P., Schmidt, B. M. W., & Halloran, P. F. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00032.x · Cited by 205 · cited 2×
“Thus, increased numbers of senescent cells were found in association with glomerulosclerosis and tubulointerstitial changes (Ding et al. 2001; Chkhotua et al. 2003; Melk et al. 2003; Melk et al. 2004).”
BackgroundMetformin‐mediated increase in DICER1 regulates microRNA expression and cellular senescence
Noren Hooten, N., Martin‐Montalvo, A., Dluzen, D. F., Zhang, Y., Bernier, M., Zonderman, A. B., Becker, K. G., Gorospe, M., Cabo, R., & Evans, M. K. (2016) · Aging Cell · doi:10.1111/acel.12469 · Cited by 196
DNA damage tolerance: a double-edged sword guarding the genome.
Ghosal, G., & Chen, J. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.04.01 · Cited by 190 · cited 1×
“Senescent cells have much in common with cancer cells, including similarities in metabolic activity, the DDR and activation of pro-survival pathways or inhibition of pro-apoptotic pathways (Ghosal and Chen 2013; Dörr et al. 2013).”
BackgroundNecessary and Sufficient Role for a Mitosis Skip in Senescence Induction
Johmura, Y., Shimada, M., Misaki, T., Naiki-Ito, A., Miyoshi, H., Motoyama, N., Ohtani, N., Hara, E., Nakamura, M., Morita, A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.003 · Cited by 182 · cited 1×
“Secondly, p53 mediates senescence independent of p21 in the G2 phase (Johmura et al. 2014).”
BackgroundCellular Senescence Limits Regenerative Capacity and Allograft Survival
Braun, H., Schmidt, B. M. W., Raiss, M., Baisantry, A., Mircea-Constantin, D., Wang, S., Gross, M.-L., Serrano, M., Schmitt, R., & Melk, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011100967 · Cited by 179
Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice
Le Clef, N., Verhulst, A., D’Haese, P. C., & Vervaet, B. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152153 · Cited by 172
Zhang, D., & Armstrong, J. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402072 · Cited by 165
Sis, B., Tasanarong, A., Khoshjou, F., Dadras, F., Solez, K., & Halloran, P. F. (2007) · Kidney International · doi:10.1038/sj.ki.5002039 · Cited by 159 · cited 5×
“For instance, kidneys with glomerular disease typically display increased expression of p16 in glomerular cell nuclei (Sis et al. 2007).”
BackgroundInfluentialThe Telomere Deprotection Response Is Functionally Distinct from the Genomic DNA Damage Response
Cesare, A. J., Hayashi, M. T., Crabbe, L., & Karlseder, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.006 · Cited by 155
Melk, A., Schmidt, B. M. W., Vongwiwatana, A., Rayner, D. C., & Halloran, P. F. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00846.x · Cited by 154 · cited 3×
“Markers of senescence are also found in glomeruli of diseased kidneys, including DN, membranous nephropathy, FSGS, minimal change disease and glomerulonephritis (Melk et al. 2005; Sis et al. 2007; Verzola et al. 2008).”
BackgroundPositive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure
Megyesi, J., Andrade, L., Vieira, J. M., Safirstein, R. L., & Price, P. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00044.x · Cited by 153 · cited 3×
“…contributing to renal aging (Wolstein et al. 2010) UUO p16-KO Acute (10d): increased renal fibrosis Beneficial: part of anti-fibrotic mechanism (Megyesi et al. 2001) IRI p21-KO Acute (<7d): impaired renal recovery, higher renal damage, higher mortality Beneficial: responsible for recovery…”
BackgroundWesthoff, J. H., Hilgers, K. F., Steinbach, M. P., Hartner, A., Klanke, B., Amann, K., & Melk, A. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.099432 · Cited by 152 · cited 6×
“…transplantation, and in various glomerular diseases, including membranous nephropathy, minimal change disease, IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS)) (Melk et al. 2005; Sis et al. 2007; Westhoff et al. 2008; Verzola et al. 2008; Liu et al. 2012a; Quimby et al. 2013).”
BackgroundInfluentialKitada, K., Nakano, D., Ohsaki, H., Hitomi, H., Minamino, T., Yatabe, J., Felder, R. A., Mori, H., Masaki, T., Kobori, H., et al. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.05.010 · Cited by 151 · cited 2×
“For example, an increase of senescence markers was observed upon renal injury in rodent models including DOCA-salt-induced hypertension, streptozotocin (STZ)-induced diabetic nephropathy (DN), and cisplatin-induced nephrotoxicity (Zhou et al. 2004; Westhoff et al. 2008; Kitada et al. 2014).”
BackgroundBiomarkers to identify and isolate senescent cells
Matjusaitis, M., Chin, G., Sarnoski, E. A., & Stolzing, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.003 · Cited by 144
Origins of G1 arrest in senescent human fibroblasts
Stein, G. H., & Dulić, V. (1995) · BioEssays · doi:10.1002/bies.950170610 · Cited by 135 · cited 2×
“Senescence has typically been linked to the G1-phase of the cell-cycle, but it does occur also in G2 (see below) (Stein and Dulić 1995; Smith and Pereira-Smith 1996).”
BackgroundCaloric restriction and genomic stability
Heydari, A. R., Unnikrishnan, A., Lucente, L. V., & Richardson, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm860 · Cited by 130 · cited 1×
“However, such a role would be compatible with the known efficacy of caloric restriction in rats, where it extended healthy lifespan and also reduced oxidative DNA damage, pro- inflammatory factors, senescence and fibrosis in the kidney (Heydari et al. 2007; Ning et al. 2013; Xu et al. 2015).”
BackgroundStress‐Induced Premature Senescence: Essence of Life, Evolution, Stress, and Aging
Toussaint, O., DUMONT, P., Dierick, J., Pascal, T. G., Frippiat, C. C., Debacq‐Chainiaux, F., Sluse, F. E., Eliaers, F., & Remacle, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06638.x · Cited by 124 · cited 1×
“1) (Campisi 1997; Toussaint et al. 2000).”
Clements, M. E., Chaber, C. J., Ledbetter, S. R., & Zuk, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070464 · Cited by 123
Chkhotua, A. B., Gabusi, E., Altimari, A., D’Errico, A., Yakubovich, M., Vienken, J., Stefoni, S., Chieco, P., Yussim, A., & Grigioni, W. F. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00363-9 · Cited by 120 · cited 1×
“Thus, increased numbers of senescent cells were found in association with glomerulosclerosis and tubulointerstitial changes (Ding et al. 2001; Chkhotua et al. 2003; Melk et al. 2003; Melk et al. 2004).”
BackgroundKamada, H., Tsutsumi, Y. M., Sato‐Kamada, K., Yamamoto, Y., Yoshioka, Y., Okamoto, T., Nakagawa, S., Nagata, S., & Mayumi, T. (2003) · Nature Biotechnology · doi:10.1038/nbt798 · Cited by 120 · cited 1×
“…including glucosamine conjugates, poly vinylpyrrolidone (PVP)-derivatives, lysozyme conjugates and other low molecular weight protein (LMWP)carriers, and also the targeting peptide (KKEEE)3 K (Franssen et al. 1993; Kamada et al. 2003; Lin et al. 2013; Falke et al. 2015; Wischnjow et al. 2016).”
BackgroundDDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 113 · cited 1×
“It is widely accepted that senescence associated prolonged G1- and G2-arrest occurs via late anti-proliferative DDR signaling in response to persistent DNA damage (Malaquin et al. 2015).”
BackgroundThe mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age
Sweetwyne, M. T., Pippin, J. W., Eng, D. G., Hudkins, K. L., Chiao, Y. A., Campbell, M. D., Marcinek, D. J., Alpers, C. E., Szeto, H. H., Rabinovitch, P. S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.036 · Cited by 112 · cited 1×
“Administration of this peptide reduces senescence of renal parietal epithelial cells (PECs) in aged mice, accompanied by attenuated glomerulosclerosis in treated mice compared to controls (Sweetwyne et al. 2017).”
BackgroundBonventre, J. V. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.8 · Cited by 110 · cited 3×
“Hence, the term Bmaladaptive regeneration/repair^ has been postulated (Bonventre 2014a).”
BackgroundEffects of Donor Age and Cell Senescence on Kidney Allograft Survival
Melk, A., Schmidt, B. M. W., Braunc, H., Vongwiwatana, A., Urmson, J., Zhu, L.-F., Rayner, D., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02500.x · Cited by 109 · cited 3×
“Additionally, in a murine model of allograft nephropathy, old donor kidneys displayed increased p16 levels, a reduced proliferation of tubular epithelial cells after transplantation, and increased susceptibility to transplantation related stress compared to kidneys from young donors (Melk et al. 2009).”
BackgroundInfluentialDing, G., Franki, N., Kapasi, A. A., Reddy, K., Gibbons, N., & Singhal, P. C. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2000.2346 · Cited by 103 · cited 1×
“Thus, increased numbers of senescent cells were found in association with glomerulosclerosis and tubulointerstitial changes (Ding et al. 2001; Chkhotua et al. 2003; Melk et al. 2003; Melk et al. 2004).”
BackgroundFolate-Conjugated Rapamycin Slows Progression of Polycystic Kidney Disease
Shillingford, J. M., Leamon, C. P., Vlahov, I. R., & Weimbs, T. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040367 · Cited by 101 · cited 1×
“Among these, megalin and folate receptor 1α have been successfully employed for targeting the proximal tubular epithelium (Prakash et al. 2008; Shillingford et al. 2012).”
BackgroundRenal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells
Wischnjow, A., Sarko, D., Janzer, M., Kaufman, C., Beijer, B., Brings, S., Haberkorn, U., Larbig, G., Kübelbeck, A., & Mier, W. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00057 · Cited by 100 · cited 1×
“…including glucosamine conjugates, poly vinylpyrrolidone (PVP)-derivatives, lysozyme conjugates and other low molecular weight protein (LMWP)carriers, and also the targeting peptide (KKEEE)3 K (Franssen et al. 1993; Kamada et al. 2003; Lin et al. 2013; Falke et al. 2015; Wischnjow et al. 2016).”
BackgroundLiu, J., Ju-rong, Y., He, Y., Cai, G., Zhang, J., Lin, L.-R., Zhan, J., Zhang, J.-H., & Xiao, H.-S. (2011) · Translational research · doi:10.1016/j.trsl.2011.11.008 · Cited by 98
Ning, Y., Cai, G., Zhuo, L., Gao, J., Dong, D. F., Cui, S., Feng, Z., Shi, S., Bai, X., Sun, X., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.006 · Cited by 98
Autophagy Induces Prosenescent Changes in Proximal Tubular S3 Segments
Baisantry, A., Bhayana, S., Rong, S., Ermeling, E., Wrede, C., Hegermann, J., Pennekamp, P., Sörensen-Zender, I., Haller, H., Melk, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111059 · Cited by 97 · cited 4×
“On the other hand, inactivation of p16 or ATG5 resulted in reduction of interstitial fibrosis and nephron atrophy later after IRI, indicating a protective longterm effect of inhibition of senescence on the development of fibrosis (Lee et al. 2012; Braun et al. 2012; Baisantry et al. 2016).”
BackgroundInfluentialImmunoliposome Targeting to Mesangial Cells
Tuffin, G., Waelti, E. R., Huwyler, J., Hammer, C., & Marti, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050485 · Cited by 86 · cited 2×
“Targeting other renal cell types (i.e. mesangial cells, endothelial cells and podocytes) is theoretically possible through targeting of different surface receptors, using nanoparticles, or with liposomes(Tuffin et al. 2005; Choi et al. 2011; Kamaly et al. 2016).”
BackgroundWolstein, J. M., Lee, D. H., Michaud, J., Buot, V., Stefanchik, B., & Plotkin, M. D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00378.2010 · Cited by 83 · cited 3×
“…of senescence (Baker et al. 2016) Natural aging (1-year old) p16-KO Attenuated glomerulosclerosis Detrimental: contributing to renal aging (Wolstein et al. 2010) UUO p16-KO Acute (10d): increased renal fibrosis Beneficial: part of anti-fibrotic mechanism (Megyesi et al. 2001) IRI p21-KO…”
BackgroundInfluentialMaladaptive Proximal Tubule Repair: Cell Cycle Arrest
Bonventre, J. V. (2014) · Nephron Clinical Practice · doi:10.1159/000363673 · Cited by 75 · cited 3×
“Hence, the term Bmaladaptive regeneration/repair^ has been postulated (Bonventre 2014a).”
BackgroundScindia, Y. M., Deshmukh, U. S., Thimmalapura, P., & Bagavant, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24026 · Cited by 72 · cited 1×
“For instance, mesangial cells, that predominantly become senescent as a consequence of hypertension and diabetic nephropathy, have been targeted through integrin α8 and Thy 1.1 using liposomes in rodents(Scindia et al. 2008; Suana et al. 2011).”
MethodInfluentialPark, J.-Y., Schutzer, W. E., Lindsley, J. N., Bagby, S. P., Oyama, T. T., Anderson, S., & Weiss, R. H. (2007) · BMC Nephrology · doi:10.1186/1471-2369-8-12 · Cited by 70
Lee, D. H., Wolstein, J. M., Pudasaini, B., & Plotkin, M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00407.2011 · Cited by 69 · cited 2×
“…fibrosis, better kidney function Beneficial: responsible for recovery after acute ischemic renal failure Detrimental: promoting renal fibrosis (Lee et al. 2012) IRI INK4a-KO Long term: improved kidney regeneration (14d), decreased capillary rarefaction (1-28d) Detrimental: promoting renal…”
BackgroundTargeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine
Lin, Y., Li, Y., Wang, X., Gong, T., Zhang, L., & Sun, X. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.02.001 · Cited by 58 · cited 1×
“Although its role in the kidney remains unclear, CCN1 expression is also elevated in several senescence-associated human pathologies beyond the liver, including atherosclerosis, which suggests a possible role in age-related diseases (Littlewood and Bennett 2007).”
BackgroundZhou, H., Kato, A., Yasuda, H., Miyaji, T., Fujigaki, Y., Yamamoto, T., Yonemura, K., & Hishida, A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.003 · Cited by 57 · cited 2×
“For example, an increase of senescence markers was observed upon renal injury in rodent models including DOCA-salt-induced hypertension, streptozotocin (STZ)-induced diabetic nephropathy (DN), and cisplatin-induced nephrotoxicity (Zhou et al. 2004; Westhoff et al. 2008; Kitada et al. 2014).”
BackgroundWahab, N. A., Cox, D., Witherden, A. S., & Mason, R. M. (2007) · Biochemical Journal · doi:10.1042/bj20061817 · Cited by 53 · cited 12×
“Indeed, genetic silencing of MKP-1 using siRNA or antisense oligonucleotides was able to induce cell apoptosis in mesangial cells treated with CCN2 (Wahab et al. 2007).”
BackgroundInfluentialKhanna, A. K., & Pieper, G. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl608 · Cited by 49 · cited 1×
“These include tacrolimus nephrotoxicity which, in rodents, involves the production of ROS and subsequent DDR, and possibly also reduction of physiological clearance of senescent cells as a result of immunosuppressive therapies (Khanna and Pieper 2007).”
BackgroundQuimby, J. M., Maranon, D. G., Battaglia, C. L. R., McLeland, S. M., Brock, W. T., & Bailey, S. M. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00527.2012 · Cited by 48 · cited 2×
“markers has also been found in diseased human and mouse kidneys in hypertension, DN, CKD, delayed graft function (DGF) after kidney transplantation, and in various glomerular diseases, including membranous nephropathy, minimal change disease, IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS)) (Melk…”
BackgroundLu, D., Rauhauser, A. A., Li, B., Ren, C., McEnery, K., Zhu, J., Chaki, M., Vadnagara, K., El-Hadi, S., Jetten, A. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.006 · Cited by 48
Suana, A., Tuffin, G., Frey, B. M., Knudsen, L., Mühlfeld, C., Rödder, S., & Marti, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.176222 · Cited by 47 · cited 1×
“For instance, mesangial cells, that predominantly become senescent as a consequence of hypertension and diabetic nephropathy, have been targeted through integrin α8 and Thy 1.1 using liposomes in rodents(Scindia et al. 2008; Suana et al. 2011).”
MethodInfluentialHochegger, K., Koppelstaetter, C., Tagwerker, A., Huber, J. M., Heininger, D., Mayer, G., & Rosenkranz, A. R. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00084.2006 · Cited by 41 · cited 1×
“…p16-KO Long term (21d): reduced interstitial fibrosis, reduced nephron atrophy Detrimental: contributing to adverse long-term allograft outcomes (Hochegger et al. 2007) IRI p53 inhibition via pifithrin-α Acute (<48 h of reperfusion): reduced serum creatinine, reduced tubular necrosis…”
BackgroundAan, G. J., Hairi, H. A., Makpol, S., Rahman, M. A., & Karsani, S. A. (2013) · ELECTROPHORESIS · doi:10.1002/elps.201300086 · Cited by 36 · cited 1×
“(Gil and Peters 2006; Aan et al. 2013).”
Xu, X.-M., Ning, Y.-C., Wang, W.-J., Liu, J.-Q., Bai, X.-Y., Sun, X.-F., Cai, G.-Y., & Chen, X.-M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430248 · Cited by 34
Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response
Jullien, L., Mestre, M., Roux, P., & Gire, V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1121 · Cited by 32 · cited 2×
“Firstly, replicative senescence applies mainly to G2 arrest as telomere attrition preferentially triggers DDR at the G2/M checkpoint (d'Adda di Fagagna 2008; Jullien et al. 2013; Mao et al. 2014).”
BackgroundLow-Molecular-Weight Proteins as Carriers for Renal Drug Targeting
Franssen, E. J. F., Moolenaar, F., de Zeeuwb, D., & Meijer, D. K. F. (2015) · Contributions to nephrology · doi:10.1159/000422115 · Cited by 16 · cited 1×
“…including glucosamine conjugates, poly vinylpyrrolidone (PVP)-derivatives, lysozyme conjugates and other low molecular weight protein (LMWP)carriers, and also the targeting peptide (KKEEE)3 K (Franssen et al. 1993; Kamada et al. 2003; Lin et al. 2013; Falke et al. 2015; Wischnjow et al. 2016).”
BackgroundMao, S., Xu, H., Zou, L., Xu, G., Wu, Z., Ding, Q., & Jiang, H. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1663 · Cited by 13 · cited 1×
“Firstly, replicative senescence applies mainly to G2 arrest as telomere attrition preferentially triggers DDR at the G2/M checkpoint (d'Adda di Fagagna 2008; Jullien et al. 2013; Mao et al. 2014).”
BackgroundFoxing Smooth Muscle Cells: FOXO3a–CYR61 Connection
Littlewood, T. D., & Bennett, M. R. (2007) · Circulation Research · doi:10.1161/01.res.0000259101.39931.d3 · Cited by 10 · cited 1×
“Although its role in the kidney remains unclear, CCN1 expression is also elevated in several senescence-associated human pathologies beyond the liver, including atherosclerosis, which suggests a possible role in age-related diseases (Littlewood and Bennett 2007).”
BackgroundNew therapies for reducing post-myocardial left ventricular remodeling.
Kloner, R. A., Shi, J., & Dai, W. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.01.13 · Cited by 8 · cited 1×
“Mitochondria-targeted therapy with SS-31 (also known as Elamipretide) is thought to stabilize cardiolipin on the inner mitochondrial membrane, thereby limiting mitochondrial dysfunction (Kloner et al. 2015).”
BackgroundInhibition of Renal Rho Kinase Attenuates Ischemia/Reperfusion-Induced Injury
Prakash, J., de Borst, M. H., Lacombe, M., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070794 · Cited by 5 · cited 1×
“Among these, megalin and folate receptor 1α have been successfully employed for targeting the proximal tubular epithelium (Prakash et al. 2008; Shillingford et al. 2012).”
BackgroundBrooksbank, C. (2001) · Nature reviews. Cancer · doi:10.1038/35101044 · Cited by 3
Research works printed but not linked: 2
- Liu J, Yang J-R, He Y-N et al (2012b) Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin a (IgA) nephropathy. Transl Res 159:454–463. https://doi.org/10.1016/j.trsl.2011.11.008 · DOI
- Matjusaitis M, Chin G, Sarnoski EA, Stolzing A (2016b) Biomarkers to identify and isolate senescent cells. Ageing Res Rev 29:1–12. https://doi.org/10.1016/j.arr.2016.05.003 · DOI · Paper page
Cited by
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
“Data from several laboratories, including our own, 52 strongly support the idea that senescent cells and the SASP drive multiple age-related 53 phenotypes and pathologies, including atherosclerosis [10], osteoarthritis [11], cancer 54 metastasis and cardiac dysfunction [12,13], myeloid skewing [14,15], kidney dysfunct…”
BackgroundTargeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979
Connective tissue growth factor (CTGF) from basics to clinics
Ramazani, Y., Knops, N., Elmonem, M. A., Nguyen, T. Q., Arcolino, F. O., van den Heuvel, L., Levtchenko, E., Kuypers, D., & Goldschmeding, R. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.007 · Cited by 329
Self-citationTherapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Saleh, T., Bloukh, S., Carpenter, V. J., Alwohoush, E., Bakeer, J., Darwish, S., Azab, B., & Gewirtz, D. A. (2020) · Cancers · doi:10.3390/cancers12040822 · Cited by 290
Iske, J., Seyda, M., Heinbokel, T., Maenosono, R., Minami, K., Nian, Y., Quante, M., Falk, C. S., Azuma, H., Martin, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18039-x · Cited by 211
Metadata
- Authors
- Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R.
- Affiliations
- University Medical Center Utrecht (NL)
- Corresponding author
- Goldschmeding, Roel
- Venue
- Journal of Cell Communication and Signaling
- Publisher
- Wiley
- Published
- 2017-12-19
- Volume
- 12
- Issue
- 1
- Pages
- 69-82
- ISSN
- 1873-9601 (ISSN-L)
- 1873-961X
- PMC
- PMC5842195
- OpenAlex
- W2780553069
- Cited by
- 173
- References
- 121
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 19 · 2023: 20 · 2022: 25 · 2021: 26 · 2020: 22 · 2019: 19 · 2018: 8
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Cell Communication and Signaling (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- University Medical Center Utrecht
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, kidney aging, kidney disease, senolytics, senotherapy, senescent cell clearance, kidney injury, cell cycle arrest, wound healing, lifespan extension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.